北京大学学报(医学版) ›› 2022, Vol. 54 ›› Issue (6): 1214-1218. doi: 10.19723/j.issn.1671-167X.2022.06.026
邢晓燕1,张筠肖2,朱冯赟智1,王一帆1,周新尧3,李玉慧1,*()
Xiao-yan XING1,Jun-xiao ZHANG2,Feng-yun-zhi ZHU1,Yi-fan WANG1,Xin-yao ZHOU3,Yu-hui LI1,*()
中图分类号:
1 |
Bohan A , Peter JB . Polymyositis and dermatomyositis (first of two parts)[J]. N Engl J Med, 1975, 292 (7): 344- 347.
doi: 10.1056/NEJM197502132920706 |
2 |
Lundberg IE , Tjarnlund A , Bottai M , et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups[J]. Ann Rheum Dis, 2017, 76 (12): 1955- 1964.
doi: 10.1136/annrheumdis-2017-211468 |
3 |
Henter JI , Horne A , Arico M , et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007, 48 (2): 124- 131.
doi: 10.1002/pbc.21039 |
4 |
Lerkvaleekul B , Vilaiyuk S . Macrophage activation syndrome: Early diagnosis is key[J]. Open Access Rheumatol, 2018, 10, 117- 128.
doi: 10.2147/OARRR.S151013 |
5 |
Kumakura S , Murakawa Y . Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults[J]. Arthritis Rheumatol, 2014, 66 (8): 2297- 2307.
doi: 10.1002/art.38672 |
6 |
Liang J , Xu D , Sun C , et al. Hemophagocytic lymphohistiocytosis: Prevalence, risk factors, outcome, and outcome-related factors in adult idiopathic inflammatory myopathies[J]. J Rheumatol, 2020, 47 (10): 1532- 1540.
doi: 10.3899/jrheum.190542 |
7 |
Minoia F , Davi S , Horne A , et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A multinational, multicenter study of 362 patients[J]. Arthritis Rheumatol, 2014, 66 (11): 3160- 3169.
doi: 10.1002/art.38802 |
8 |
Tang S , Li S , Zheng S , et al. Understanding of cytokines and targeted therapy in macrophage activation syndrome[J]. Semin Arthritis Rheum, 2021, 51 (1): 198- 210.
doi: 10.1016/j.semarthrit.2020.12.007 |
9 |
Kostik MM , Dubko MF , Masalova VV , et al. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis[J]. Semin Arthritis Rheum, 2015, 44 (4): 417- 422.
doi: 10.1016/j.semarthrit.2014.09.004 |
10 |
Fardet L , Galicier L , Lambotte O , et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome[J]. Arthritis Rheumatol, 2014, 66 (9): 2613- 2620.
doi: 10.1002/art.38690 |
11 |
Schulert GS . The storm beneath the storm: MAS-HLH in inflammatory myopathies[J]. J Rheumatol, 2020, 47 (10): 1461- 1463.
doi: 10.3899/jrheum.191274 |
12 |
Gono T , Kawaguchi Y , Ozeki E , et al. Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis[J]. Mod Rheumatol, 2011, 21 (2): 223- 227.
doi: 10.3109/s10165-010-0371-x |
13 |
La Rosee P , Horne A , Hines M , et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults[J]. Blood, 2019, 133 (23): 2465- 2477.
doi: 10.1182/blood.2018894618 |
14 |
Canna SW , Girard C , Malle L , et al. Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition[J]. J Allergy Clin Immunol, 2017, 139 (5): 1698- 1701.
doi: 10.1016/j.jaci.2016.10.022 |
15 |
Gabr JB , Liu E , Mian S , et al. Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: Case report and review of the literature[J]. Ann Transl Med, 2020, 8 (14): 887.
doi: 10.21037/atm-20-3127 |
16 |
Ahmed A , Merrill SA , Alsawah F , et al. Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: An open-label, single-centre, pilot trial[J]. Lancet Haematol, 2019, 6 (12): e630- e637.
doi: 10.1016/S2352-3026(19)30156-5 |
17 |
Verweyen E , Holzinger D , Weinhage T , et al. Synergistic signaling of TLR and IFNalpha/beta facilitates escape of IL-18 expression from endotoxin tolerance[J]. Am J Respir Crit Care Med, 2020, 201 (5): 526- 539.
doi: 10.1164/rccm.201903-0659OC |
18 | Wu J, Sun L, Tang X, et al. Effective therapy of tocilizumab on systemic juvenile idiopathic arthritis associated refractory macrophage activation syndrome[J]. Mod Rheumatol, 2021[2022-08-01]. https://doi.org/10.1093/mr/roab119. |
19 |
Fujita Y , Fukui S , Suzuki T , et al. Anti-MDA5 antibody-positive dermatomyositis complicated by autoimmune-associated hemophagocytic syndrome that was successfully treated with immunosuppressive therapy and plasmapheresis[J]. Intern Med, 2018, 57 (23): 3473- 3478.
doi: 10.2169/internalmedicine.1121-18 |
20 |
Kaieda S , Yoshida N , Yamashita F , et al. Successful treatment of macrophage activation syndrome in a patient with dermatomyositis by combination with immunosuppressive therapy and plasmapheresis[J]. Mod Rheumatol, 2015, 25 (6): 962- 966.
doi: 10.3109/14397595.2013.844402 |
21 |
Komiya Y , Saito T , Mizoguchi F , et al. Hemophagocytic syndrome complicated with dermatomyositis controlled successfully with infliximab and conventional therapies[J]. Intern Med, 2017, 56 (23): 3237- 3241.
doi: 10.2169/internalmedicine.7966-16 |
22 |
Sasaki H , Kohsaka H . Current diagnosis and treatment of polymyositis and dermatomyositis[J]. Mod Rheumatol, 2018, 28 (6): 913- 921.
doi: 10.1080/14397595.2018.1467257 |
23 |
Gavand PE , Serio I , Arnaud L , et al. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients[J]. Autoimmun Rev, 2017, 16 (7): 743- 749.
doi: 10.1016/j.autrev.2017.05.010 |
[1] | 朱晓娟,张虹,张爽,李东,李鑫,徐玲,李挺. 人表皮生长因子受体2低表达乳腺癌的临床病理学特征及预后[J]. 北京大学学报(医学版), 2023, 55(2): 243-253. |
[2] | 赖玉梅,李忠武,李欢,吴艳,时云飞,周立新,楼雨彤,崔传亮. 68例肛管直肠黏膜黑色素瘤临床病理特征及预后[J]. 北京大学学报(医学版), 2023, 55(2): 262-269. |
[3] | 沈棋,刘亿骁,何群. 肾黏液样小管状和梭形细胞癌的临床病理特点及预后[J]. 北京大学学报(医学版), 2023, 55(2): 276-282. |
[4] | 曹芳,钟明,刘从容. 宫体POLE突变型内膜样癌合并HPV感染相关性宫颈腺癌1例报道及文献回顾[J]. 北京大学学报(医学版), 2023, 55(2): 370-374. |
[5] | 叶一林,刘恒,潘利平,柴卫兵. 全膝关节置换术后假体周围痛风发作误诊1例[J]. 北京大学学报(医学版), 2023, 55(2): 362-365. |
[6] | 宿骞,彭歆,周传香,俞光岩. 369例口腔颌面部非霍奇金淋巴瘤的临床病理特点及预后[J]. 北京大学学报(医学版), 2023, 55(1): 13-21. |
[7] | 张铨,宋海峰,马冰磊,张喆楠,周朝晖,李傲林,刘军,梁磊,朱时雨,张骞. 术前预后营养指数可作为预测非转移性肾细胞癌预后的指标[J]. 北京大学学报(医学版), 2023, 55(1): 149-155. |
[8] | 徐朝焰,林长艺,叶达梅,吴培埕,宋明辉,刘有添,邓琼,黄雪艳,范忠晓,游雪兰. 感染性关节炎诊断分析[J]. 北京大学学报(医学版), 2022, 54(6): 1234-1237. |
[9] | 曹乐清,周婧睿,陈育红,陈欢,韩伟,陈瑶,张圆圆,闫晨华,程翼飞,莫晓冬,付海霞,韩婷婷,吕萌,孔军,孙于谦,王昱,许兰平,张晓辉,黄晓军. 异基因造血干细胞移植后晚发重症肺炎患者治疗与预后转归的关系[J]. 北京大学学报(医学版), 2022, 54(5): 1013-1020. |
[10] | 张崔建,何志嵩,周利群. 上尿路尿路上皮癌的淋巴清扫[J]. 北京大学学报(医学版), 2022, 54(4): 592-594. |
[11] | 邱敏,连岩岩,陆敏,王滨帅,田晓军,卢剑,刘承,张树栋,姜敏,马潞林. 多原发癌合并肾癌的治疗及预后[J]. 北京大学学报(医学版), 2022, 54(4): 680-685. |
[12] | 博尔术,洪鹏,张宇,邓绍晖,葛力源,陆敏,李楠,马潞林,张树栋. 乳头状肾细胞癌的临床病理特征和预后分析[J]. 北京大学学报(医学版), 2022, 54(4): 615-620. |
[13] | 康志宇,王磊磊,韩永正,郭向阳. 北京冬季奥林匹克运动会运动员手术的麻醉管理[J]. 北京大学学报(医学版), 2022, 54(4): 770-773. |
[14] | 邓宇含,姜勇,王子尧,刘爽,汪雨欣,刘宝花. 基于长短期记忆网络和Logistic回归的重症监护病房脑卒中患者院内死亡风险预测[J]. 北京大学学报(医学版), 2022, 54(3): 458-467. |
[15] | 于博,赵扬玉,张喆,王永清. 妊娠合并感染性心内膜炎1例[J]. 北京大学学报(医学版), 2022, 54(3): 578-580. |
|